KELLY THOMAS PATRICK (Chief Financial Officer) sold 3.6% of their position (3.01K shares) of DECIPHERA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $47.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/20/2024ACC: 0000950170-24-017091
Officer· Chief Financial Officer
Since Jan 2019
+83.36K
Net shares
Net buyer
$47.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
86.38K acquired · 3.01K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+17.27K
Price / share
—
Trade value
—
% of position
26.1%
2/15/2024
66.08K→83.36K
Common Stock
Direct
Shares
−3.01K
Price / share
$15.62
Trade value
$47.01K
% of position
3.6%
2/16/2024
83.36K→80.35K
Total
Net shares
+14.27K
Net value
-$47.01K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/15/2024 | A · Award | +17.27K | — | — | 26.1% | 66.08K | 83.36K |
| Common Stock Direct | 2/16/2024 | S · Sale | −3.01K | $15.62 | $47.01K | 3.6% | 83.36K | 80.35K |
| Total | +14.27K | -$47.01K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
69.10K shares
Shares
+69.10K
Strike price
15.92
Held after
69.10K
Exercisable
—
2/15/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock69.10K shares | 2/15/2024 | A · Award | +69.10K | 15.92 | — | 69.10K |